Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Reference10 articles.
1. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY et al (1993) Somatostatin receptor scintigraphy with (111In-DTPA-D-Phe1)- and (123I-Tyr3)-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20(8):716–731
2. Ambrosini V, Campana D, Bodei L, Nanni C, Castelucci P, Allegri V et al (2010) 68 Ga-DOTANOC PET-CT clinical impact in patients with neuroendocrine tumors. J Nucl Med 51(5):669–673
3. Castellucci P, Ucha JP, Fuccio C, Rubello D, Ambrosini V, Montini GC et al (2011) Incidence of increased 68 Ga-DOTANOC uptake in the pancreatic head in a large series of extrapancreatic NET patients studied with sequential PET/CT. J Nucl Med 52(6):886–890
4. Decristoforo C, Mather SJ, Cholewinski W, Donnemiller E, Riccabona G, Moncayo R (2000) 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives. Eur J Nucl Med 27:1318–1325
5. Gabriel C, Mather SJ, Moncayo RM, Decristoforo C, Donnemiller E, Ulmer H et al (2003) An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors. J Nucl Med 44(5):708–716
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献